Wall Street is positive on TherapeuticsMD Inc (TXMD). On average, analysts give TherapeuticsMD Inc a Hold rating. The average price target is $5, which means analysts expect the stock to increase by 143.90% over the next twelve months. That average ranking earns TherapeuticsMD Inc an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating TXMD a Hold today. Find out what this means to you and get the rest of the rankings on TXMD!